Medication Overuse Headache*

References

• Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999;39:190–6
   PubMed Web of Science ®Google Scholar
• Granella F, Farina S, Malferrari G, Manzoni GC. Drug abuse in chronic headache: a clinico-epidemiologic study. Cephalalgia 1987;7:15–19
   PubMed Web of Science ®Google Scholar
• Micieli G, Manzoni GC, Granella F, et al. Clinical and epidemiological observations on drug abuse in headache patients. In: Diener HC, Wilkinson M, eds. Drug-Induced Headache. Berlin, Heidelberg, New York: Springer; 1988: 20–8
   Google Scholar
• Rapoport A, Stang P, Gutterman DL, et al. Analgesic rebound headache in clinical practice: data from a physician survey. Headache 1996;36: 14–19
   Google Scholar
• Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular analgesic use? Cephalalgia 2000;20:294 [abstract]
   Google Scholar
• Lance F, Parkes C, Wilkinson M. Does analgesic abuse cause headache de novo? Headache 1988;38:61–2
   Google Scholar
• Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992;327:1109–14
   PubMed Web of Science ®Google Scholar
• van Dusseldorp M, Katan MB. Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12 week double blind trial. Br Med J 1990;300:1558–9
   PubMed Web of Science ®Google Scholar
• Fisher MA, Glass S. Butorphanol (Stadol): A study in problems of current drug information and control. Neurology 1997;48:1156–60
   PubMed Web of Science ®Google Scholar
• Ziegler DK. Opiate and opioid use in patients with refractory headache. Cephalalgia 1994;14:5–10
   PubMed Web of Science ®Google Scholar
• Saper JR, Jones JM. Ergotamine tartrate dependency: features and possible mechanisms. Clin Neuropharmacol 1986;9:244–56
   PubMed Web of Science ®Google Scholar
• Fanciullacci M, Alessandri M, Pietrini U, et al. Long-term ergotamine abuse: effect on adrenergically induced mydriasis. Clin Pharm Ther 1992;51: 302–7
   Google Scholar
• Diener HC, Dahlöf CGH. Headache associated with chronic use of substances. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches, 2nd edn. Philadelphia: Lippincott Williams & Wilkins, 1999:871–8
   Google Scholar
• Rapoport A, Weeks R, Sheftell F. Analgesic rebound headache: theoretical and practical implications. Cephalalgia 1985;5 Suppl 3: 448–9
   Google Scholar
• Baumgartner C, Wessely P, Bingöl C, et al. Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 1989;29:510–14
   PubMed Web of Science ®Google Scholar
• Diener HC, Bühler K, Dichgans J, et al. Analgetikainduzierter Dauerkopfschmerz. Existiert eine kritische Dosis? Arzneimitteltherapie 1988;6:156–64
   Google Scholar
• Mathew NT, Kurman R, Perez F. Drug induced refractory headache – clinical features and management. Headache 1990;30:634–8
   PubMed Web of Science ®Google Scholar
• Catarci T, Fiacco F, Argentino C, et al. Ergotamine-induced headache can be sustained by sumatriptan daily intake. Cephalalgia 1994;14:374–5
   PubMed Web of Science ®Google Scholar
• Kaube H, May A, Diener HC, Pfaffenrath V. Sumatriptan misuse in daily chronic headache. Br Med J 1994;308:1573
   PubMed Web of Science ®Google Scholar
• Gaist D, Hallas J, Sindrup SH, Gram LF. Is overuse of sumatriptan a problem? A population-based study. Eur J Clin Pharmacol 1996;3:161–5
   Google Scholar
• Gaist D, Tsiropoulus I, Sindrup SH, et al. Inappropriate use of sumatriptan: population based register and interview study. Br J Med 1998;316: 1352–3
   Google Scholar
• Pini LA, Trenti T. Case report: does chronic use of sumatriptan induce dependence? Headache 1994;34:600–1
   PubMed Web of Science ®Google Scholar
• Katsarava Z, Fritsche G, Diener HC, Limmroth V. Drug-induced headache (DIH) following the use of different triptans. Cephalalgia 2000;20:293 [abstract]
   Google Scholar
• Limmroth V, Kazarawa S, Fritsche G, Diener HC. Headache after frequent use of new 5-HT agonists zolmitriptan and naratriptan. Lancet 1999;353:378
   PubMed Web of Science ®Google Scholar
• Schnider P, Aull S, Baumgartner C, et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five year follow-up. Cephalalgia 1996;16: 481–5
   Google Scholar
• Diener HC, Dichgans J, Scholz E, et al. Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 1989;236: 9–14
   Google Scholar
• Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet 1991; 337:1442–3
   PubMed Web of Science ®Google Scholar
• Haag G, Baar H, Grotemeyer KH, et al. Prophylaxe und Therapie des medikamenteninduzierten Dauerkopfschmerzes. Schmerz 1999;13:52–7
   PubMed Web of Science ®Google Scholar
• Mathew NT, Ali S. Valproate in the treatment of persistent chronic daily headache. An open labeled study. Headache 1991;31:71–4
   Google Scholar
• Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 2000;20:107–13
   PubMed Web of Science ®Google Scholar
• Diener HC, Haab J, Peters C, et al. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache 1990;31: 205–9
   Web of Science ®Google Scholar
• Mathew NT. Amelioration of ergotamine withdrawal with naproxen. Headache 1987;27:130–3
   PubMed Web of Science ®Google Scholar
• Peters GA, Horton BT. Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proceed Staff Meet Mayo Clin 1951;26: 153–61
   PubMed Web of Science ®Google Scholar